trxade.com is quickly becoming the nation's largest web-based pharmaceutical purchasing and analytics system. our revolutionary supplier e-stores allow buyers to shop and compare products and pricing of pharmaceutical suppliers nationwide. this forward thinking platform creates supplier competition and drives down cost for the buyers like never before. our secure system also allows buyers to track all of their purchases in one, easy to manage location with analytical tools available to make more educated and informed purchasing decisions. trxade.com membership is offered only to licensed pharmaceutical buyers (pharmacies, long term care facilities, hospitals, physicians, etc.). our safe and secure system allows buyers to search for products, compare pricing and submit immediate purchase orders to some of the nation's most well known and respected suppliers.
Company profile
Ticker
MEDS
Exchange
Website
CEO
Surendra Kumar Ajjarapu
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Bluebird Exploration Co., TRXADE GROUP, INC., XCELLINK INTERNATIONAL INC.
SEC CIK
Corporate docs
Subsidiaries
Trxade, Inc. • Integra Pharma Solutions, Inc. • Bonum Health, Inc • Bonum Health, LLC ...
MEDS stock data
Latest filings (excl ownership)
10-K
2023 FY
Annual report
22 Apr 24
NT 10-K
Notice of late annual filing
2 Apr 24
8-K
TRxADE Health, Inc. Announces Special Cash Dividend
6 Mar 24
SEC STAFF ACTION
SEC staff action: Order
26 Feb 24
8-K
Entry into a Material Definitive Agreement
16 Feb 24
8-K
Other Events
17 Jan 24
10-Q
2023 Q3
Quarterly report
16 Jan 24
8-K
Entry into a Material Definitive Agreement
11 Jan 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
28 Nov 23
8-K
Other Events
20 Nov 23
Transcripts
MEDS
Earnings call transcript
2023 Q1
15 May 23
MEDS
Earnings call transcript
2022 Q4
27 Mar 23
MEDS
Earnings call transcript
2022 Q3
8 Nov 22
MEDS
Earnings call transcript
2022 Q2
26 Jul 22
MEDS
Earnings call transcript
2022 Q1
10 May 22
MEDS
Earnings call transcript
2021 Q4
29 Mar 22
MEDS
Earnings call transcript
2021 Q3
26 Oct 21
MEDS
Earnings call transcript
2021 Q2
27 Jul 21
MEDS
Earnings call transcript
2021 Q1
27 Apr 21
MEDS
Earnings call transcript
2020 Q4
30 Mar 21
Latest ownership filings
SC 13G/A
ARMISTICE CAPITAL, LLC
14 Feb 24
4
Prashant Patel
16 Jan 24
4
SURENDRA K AJJARAPU
16 Jan 24
4
Janet Huffman
24 Feb 23
SC 13G
ARMISTICE CAPITAL, LLC
14 Feb 23
4
MICHAEL L PETERSON
20 Jan 23
3
MICHAEL L PETERSON
6 Jan 23
4
A. Jeffrey Newell
30 Dec 22
SC 13D/A
AJJARAPU SURENDRA K
19 Oct 22
SC 13D/A
Patel Prashant
19 Oct 22
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 34.03 k | 34.03 k | 34.03 k | 34.03 k | 34.03 k | 34.03 k |
Cash burn (monthly) | 237.18 k | 23.97 k | 281.72 k | 342.40 k | 201.04 k | (no burn) |
Cash used (since last report) | 1.62 mm | 163.59 k | 1.92 mm | 2.34 mm | 1.37 mm | n/a |
Cash remaining | -1.58 mm | -129.56 k | -1.89 mm | -2.30 mm | -1.34 mm | n/a |
Runway (months of cash) | -6.7 | -5.4 | -6.7 | -6.7 | -6.7 | n/a |
Institutional ownership, Q2 2023
1.9% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 6 |
Opened positions | 4 |
Closed positions | 10 |
Increased positions | 0 |
Reduced positions | 2 |
13F shares | Current |
---|---|
Total value | 233.17 mm |
Total shares | 22.65 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
MS Morgan Stanley | 13.87 k | $180.96 mm |
BCS Barclays | 4.80 k | $63.00 k |
Tower Research Capital | 2.14 k | $27.86 mm |
UBS UBS Group AG - Registered Shares | 900.00 | $11.75 mm |
JPM JPMorgan Chase & Co. | 884.00 | $11.54 mm |
RY Royal Bank Of Canada | 67.00 | $1.00 mm |
Proequities | 0.00 | $0.00 |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
5 Jan 24 | Patel Prashant | Common stock | Grant | Acquire A | Yes | No | 0 | 150,000 | 0.00 | 150,000 |
5 Jan 24 | Ajjarapu Surendra K | Common stock | Grant | Acquire A | Yes | No | 0 | 150,000 | 0.00 | 150,000 |
16 Jan 23 | Peterson Michael L | Common stock | Grant | Acquire A | No | No | 0 | 100,000 | 0.00 | 118,940 |
16 Jan 23 | Peterson Michael L | Stock Option Common Stock | Grant | Acquire A | No | No | 0 | 135,802 | 0.00 | 135,802 |
30 Dec 22 | A. Jeffrey Newell | Common stock | Grant | Acquire A | No | No | 0 | 79,062 | 0.00 | 79,062 |
News
12 Health Care Stocks Moving In Friday's Intraday Session
5 Apr 24
12 Health Care Stocks Moving In Monday's Intraday Session
25 Mar 24
12 Health Care Stocks Moving In Monday's Pre-Market Session
25 Mar 24
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
20 Mar 24
12 Health Care Stocks Moving In Tuesday's After-Market Session
19 Mar 24
Press releases
TRxADE Health, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K
23 Apr 24
Market Momentum: Analyzing Five Stocks Exhibiting Strong Upward Trends: INBS, MEDS, IFBD, AISP, VTAK
7 Mar 24
Recent Market Movers: Healthcare Companies Making Headlines: DYAI, RIGL, ARDX, VERO, MEDS
28 Feb 24
Thinking about buying stock in Trxade Health, Brookmount Gold, Columbia Banking System, ZK International Group, or Universe Pharmaceuticals?
20 Feb 24